Composition and method of treating depression using a pentacyclic nucleus opioid antagonist in combination with a tricyclic antidepressant
AssigneeJohn S. Nagle, Esq.
InventorLee G. Dante
Life of this patent
Estimating the term…
Abstract
A new composition and method for treating depression is claimed comprising administering to a patient exhibiting said illness or illnesses a pharmacologically effective dose of an opioid antagonist having a pentacyclic nucleus, and a pharmacologically effective dose of a tricyclic antidepressant.
Claims8
A method of treating depression comprising administering to a patient a pharmacologically effective dose of an opioid antagonist having a pentacyclic nucleus structurally analogous to naloxone, naltrexone, and nalmafene, and a pharmacologically effective dose of at least one tricyclic antidepressant.
A composition for treating depression comprising a pharmacologically effective dose of an opioid antagonist having a pentacyclic nucleus structurally analogous to naloxone, naltrexone, and nalmafene, and a pharmacologically effective dose of at least one tricyclic antidepressant.
Dependencies are inferred from the claim text.